Current status of idiopathic nonspecific interstitial pneumonia

Seminars in Respiratory and Critical Care Medicine

Volumn 33, Issue 5, 2012, Pages 440-449

  Poletti, Venerino ^a   Romagnoli, Micaela ^a   Piciucchi, Sara ^a   Chilosi, Marco ^b  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

bronchoalveolar lavage; clinical classification; cyclophosphamide; high resolution CT scan; idiopathic nonspecific interstitial pneumonia; rituximab; transbronchial lung biopsy

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; AZATHIOPRINE; BORTEZOMIB; CAVEOLIN 1; COLLAGEN TYPE 1; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GAMMA INTERFERON; IMMUNOGLOBULIN G4; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 4; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTEIN C; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA;

ACUTE LUNG INJURY; ALLERGIC PNEUMONITIS; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; AUTOIMMUNE DISEASE; BLOOD ANALYSIS; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CAPILLAROSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; COUGHING; DERMATOMYOSITIS; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DYSPNEA; ELECTROMYOGRAPHY; ENVIRONMENTAL EXPOSURE; EPSTEIN BARR VIRUS; ERYTHROCYTE SEDIMENTATION RATE; FORCED VITAL CAPACITY; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GRAFT VERSUS HOST REACTION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPOXEMIA; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG LAVAGE; LUNG TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOSIS; MYELODYSPLASTIC SYNDROME; OCCUPATIONAL EXPOSURE; ORGANIZING PNEUMONIA; PATHOGENESIS; PHYSICAL EXAMINATION; PNEUMOCYSTIS JIROVECI; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCHIRMER TEST; SEROLOGY; SINUS HISTIOCYTOSIS; SMOKING; THORAX RADIOGRAPHY; WNT SIGNALING PATHWAY;

BRONCHOALVEOLAR LAVAGE; FEMALE; GLUCOCORTICOIDS; HUMANS; IDIOPATHIC INTERSTITIAL PNEUMONIAS; IMMUNOSUPPRESSIVE AGENTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84866498884     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0032-1325155     Document Type: Article

References (91)

1. Liebow A. A., Carrington C. B. The interstitial pneumonias. In: Simon M., Potchen E. J., LeMay M., eds. Frontiers of Pulmonary Radiology: Pathophysiologic, Roentgenographic and Radioisotopic Considerations. New York Grune & Stratton: 1969; 102 141
2. Kuhn C. Chronic infiltrative lung disease: new insights in pathology. The Fleischner Society. 26th Annual Conference on Chest Disease; Vancouver, British Columbia; 1996:2534
3. Kitaichi M. Pathologic features and the classification of interstitial pneumonia of unknown etiology. Bull Chest Dis Res Inst Kyoto Univ: 1990; 23 1-2 1 18
4. Colby T. V., Carrington C. B. Infiltrative lung disease. In: Thurlbeck W. M., ed. Pathology of the Lung. New York Thieme: 1988; 425 517
5. Ognibene F. P., Masur H., Rogers P., et al. Nonspecific interstitial pneumonitis without evidence of Pneumocystis carinii in asymptomatic patients infected with human immunodeficiency virus (HIV). Ann Intern Med: 1988; 109 11 874 879 (Pubitemid 19000027)
6. Katzenstein A. L., Fiorelli R. F. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol: 1994; 18 2 136 147 (Pubitemid 24046413)
7. Lee J. W., Lee K. S., Lee H. Y., et al. Cryptogenic organizing pneumonia: serial high-resolution CT findings in 22 patients. AJR Am J Roentgenol: 2010; 195 4 916 922
8. Shrestha B., Sekiguchi H., Colby T. V., et al. Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am J Surg Pathol: 2009; 33 10 1450 1462
9. Farris A. B. III, Hasserjian R. P., Zukerberg L. R., et al. Diffuse cellular and fibrosing interstitial pneumonitis with desquamative interstitial pneumonitis-like features associated with myeloid neoplasia. Am J Surg Pathol: 2009; 33 10 1485 1493
10. Travis W. D., Hunninghake G., King T. E. Jr., et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med: 2008; 177 12 1338 1347 (Pubitemid 351860911)
11. Kinder B. W., Collard H. R., Koth L., et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med: 2007; 176 7 691 697 (Pubitemid 47503077)
12. Romagnoli M., Nannini C., Piciucchi S., et al. Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders? Eur Respir J: 2011; 38 2 384 391
13. Travis W. D., Matsui K., Moss J., Ferrans V. J. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol: 2000; 24 1 19 33 (Pubitemid 30033393)
14. Reghellin D., Poletti V., Tomassett S., et al. Cathepsin K is a sensitive immunohistochemical marker for detection of micro-granulomas in hypersensitivity pneumonitis. Sarcoidosis Vasc Diffuse Lung Dis: 2010; 27 1 57 63
15. Chilosi M., Poletti V., Murer B., et al. Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63. Lab Invest: 2002; 82 10 1335 1345 (Pubitemid 35191537)
16. Chilosi M., Zamò A., Doglioni C., et al. Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis. Respir Res: 2006; 7 95
17. Tansey D., Wells A. U., Colby T. V., et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology: 2004; 44 6 585 596 (Pubitemid 38845105)
18. de Carvalho E. F., Parra E. R., de Souza R., A'b Saber A. M., Machado JdeC, Capelozzi V. L. Arterial and interstitial remodelling processes in non-specific interstitial pneumonia: systemic sclerosis versus idiopathic. Histopathology: 2008; 53 2 195 204 (Pubitemid 352032770)
19. Kim D. S., Yoo B., Lee J. S., et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis: 2002; 19 2 121 127 (Pubitemid 34685911)
20. Yousem S. A. The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. Hum Pathol: 1995; 26 6 668 675
21. Flaherty K. R., Travis W. D., Colby T. V., et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med: 2001; 164 9 1722 1727 (Pubitemid 33124165)
22. Nicholson A. G., Addis B. J., Bharucha H., et al. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax: 2004; 59 6 500 505 (Pubitemid 38797523)
23. Poletti V., Kitaichi M. Facts and controversies in the classification of idiopathic interstitial pneumonias. Sarcoidosis Vasc Diffuse Lung Dis: 2000; 17 3 229 238
24. Watanabe K., Higuchi K., Ninomiya K., et al. Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia. Eur Respir J: 2002; 20 5 1213 1219 (Pubitemid 35331880)
25. Romagnoli M., Bigliazzi C., Casoni G. L., et al. The role of transbronchial lung biopsy for the diagnosis of diffuse drug-induced lung disease: a case series of 44 patients. Sarcoidosis Vasc Diffuse Lung Dis: 2008; 25 1 36 45
26. Casoni G. L., Gurioli C., Chhajed P. N., et al. The value of transbronchial lung biopsy using jumbo forceps via rigid bronchoscope in diffuse lung disease. Monaldi Arch Chest Dis: 2008; 69 2 59 64
27. Babiak A., Hetzel J., Krishna G., et al. Transbronchial cryobiopsy: a new tool for lung biopsies. Respiration: 2009; 78 2 203 208
28. Ohshimo S., Bonella F., Cui A., et al. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med: 2009; 179 11 1043 1047
29. Ryu Y. J., Chung M. P., Han J., et al. Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias. Respir Med: 2007; 101 3 655 660 (Pubitemid 46196313)
30. Welker L., Jörres R. A., Costabel U., Magnussen H. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J: 2004; 24 6 1000 1006 (Pubitemid 39642292)
31. Veeraraghavan S., Latsi P. I., Wells A. U., et al. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur Respir J: 2003; 22 2 239 244 (Pubitemid 36986991)
32. Kim E. Y., Lee K. S., Chung M. P., Kwon O. J., Kim T. S., Hwang J. H. Nonspecific interstitial pneumonia with fibrosis: serial high-resolution CT findings with functional correlation. AJR Am J Roentgenol: 1999; 173 4 949 953 (Pubitemid 29451291)
33. MacDonald S. L., Rubens M. B., Hansell D. M., et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology: 2001; 221 3 600 605 (Pubitemid 33101748)
34. Hozumi H., Nakamura Y., Johkoh T., et al. Nonspecific interstitial pneumonia: prognostic significance of high-resolution computed tomography in 59 patients. J Comput Assist Tomogr: 2011; 35 5 583 589
35. Souza C. A., Müller N. L., Lee K. S., Johkoh T., Mitsuhiro H., Chong S. Idiopathic interstitial pneumonias: prevalence of mediastinal lymph node enlargement in 206 patients. AJR Am J Roentgenol: 2006; 186 4 995 999 (Pubitemid 46100198)
36. Ambrosini V., Zompatori M., De Luca F., et al. 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results. J Nucl Med: 2010; 51 12 1950 1955
37. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med: 2002; 165 2 277 304
38. Nagai S., Kitaichi M., Itoh H., Nishimura K., Izumi T., Colby T. V. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J: 1998; 12 5 1010 1019 (Pubitemid 28545604)
39. Meliconi R., Bestagno M., Sturani C., et al. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease. Clin Exp Immunol: 1989; 76 2 184 189 (Pubitemid 19150386)
40. Nakos G., Adams A., Andriopoulos N. Antibodies to collagen in patients with idiopathic pulmonary fibrosis. Chest: 1993; 103 4 1051 1058 (Pubitemid 23110269)
41. Yamadori I., Fujita J., Bandoh S., et al. Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjögren's syndrome. Rheumatol Int: 2002; 22 3 89 92 (Pubitemid 34983823)
42. Tzelepis G. E., Toya S. P., Moutsopoulos H. M. Occult connective tissue diseases mimicking idiopathic interstitial pneumonias. Eur Respir J: 2008; 31 1 11 20
43. Sato T., Fujita J., Yamadori I., et al. Non-specific interstitial pneumonia; as the first clinical presentation of various collagen vascular disorders. Rheumatol Int: 2006; 26 6 551 555
44. Park I. N., Jegal Y., Kim D. S., et al. Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J: 2009; 33 1 68 76
45. Fujita J., Ohtsuki Y., Yoshinouchi T., et al. Idiopathic non-specific interstitial pneumonia: as an "autoimmune interstitial pneumoniao" Respir Med: 2005; 99 2 234 240 (Pubitemid 40104280)
46. Vancheri C., Failla M., Crimi N., Raghu G. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J: 2010; 35 3 496 504
47. Chilosi M., Poletti V., Rossi A. The pathogenesis of COPD and IPF: distinct horns of the same devil? Respir Res: 2012; 13 3
48. Cottin V., Nunes H., Brillet P. Y., et al. Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J: 2005; 26 4 586 593 (Pubitemid 41448654)
49. Marten K., Milne D., Antoniou K. M., et al. Non-specific interstitial pneumonia in cigarette smokers: a CT study. Eur Radiol: 2009; 19 7 1679 1685
50. Washko G. R., Hunninghake G. M., Fernandez I. E., et al. COPDGene Investigators. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med: 2011; 364 10 897 906
51. Samara K. D., Margaritopoulos G., Wells A. U., Siafakas N. M., Antoniou K. M. Smoking and pulmonary fibrosis: novel insights. Pulm Med: 2011; 2011 461439. Epub 2011 Jun 15
52. Chilosi M., Doglioni C., Murer B., Poletti V. Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis: 2010; 27 1 7 18
53. Königshoff M., Dumitrascu R., Udalov S., et al. Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention. Thorax: 2010; 65 11 949 955
54. Casoni G. L., Ulivi P., Mercatali L., et al. Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis. Int J Biol Markers: 2010; 25 4 229 235
55. Jinta T., Miyazaki Y., Kishi M., et al. The pathogenesis of chronic hypersensitivity pneumonitis in common with idiopathic pulmonary fibrosis: expression of apoptotic markers. Am J Clin Pathol: 2010; 134 4 613 620
56. Watanabe K., Handa T., Tanizawa K., et al. Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. Respir Med: 2011; 105 8 1238 1247
57. Okayasu K., Ohtani Y., Takemura T., et al. Nonspecific interstitial pneumonia (NSIP) associated with anti-KS antibody: differentiation from idiopathic NSIP. Intern Med: 2009; 48 15 1301 1306
58. Okamoto M., Hoshino T., Kitasato Y., et al. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J: 2011; 37 5 1119 1127
59. Baroni S. S., Santillo M., Bevilacqua F., et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med: 2006; 354 25 2667 2676
60. Martinez F. J., Flaherty K. R. Nonspecific interstitial pneumonia. In: Schwarz M. I., King T. E., eds. Interstitial Lung Disease. 5th ed. Shelton, CT People's Medical Publishing House: 2011; 945 959
61. Schneider F., Hwang D. M., Gibson K., Yousem S. A. Nonspecific interstitial pneumonia: a study of 6 patients with progressive disease. Am J Surg Pathol: 2012; 36 1 89 93
62. Gaxiola M., Buendía-Roldán I., Mejía M., et al. Morphologic diversity of chronic pigeon breeder's disease: clinical features and survival. Respir Med: 2011; 105 4 608 614
63. Lee J. Y., Chung J. H., Lee Y. J., et al. Propylthiouracil-induced nonspecific interstitial pneumonia. Chest: 2011; 139 3 687 690
64. Sattler F., Nichols L., Hirano L., et al. Nonspecific interstitial pneumonitis mimicking Pneumocystis carinii pneumonia. Am J Respir Crit Care Med: 1997; 156 3 Pt 1 912 917 (Pubitemid 27396435)
65. Yu H., Fujita J., Higa F., et al. Nonspecific interstitial pneumonia pattern as pulmonary involvement in human T-cell lymphotropic virus type 1 carriers. J Infect Chemother: 2009; 15 5 284 287
66. Chilosi M., Zinzani P. L., Poletti V. Lymphoproliferative lung disorders. Semin Respir Crit Care Med: 2005; 26 5 490 501 (Pubitemid 41552378)
67. Latsi P. I., du Bois R. M., Nicholson A. G., et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med: 2003; 168 5 531 537 (Pubitemid 37088594)
68. Silva C. I., Müller N. L., Hansell D. M., Lee K. S., Nicholson A. G., Wells A. U. Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time. Radiology: 2008; 247 1 251 259
69. Hartman T. E., Swensen S. J., Hansell D. M., et al. Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology: 2000; 217 3 701 705
70. Bnà C., Zompatori M., Poletti V., et al. Differential diagnosis between usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP) assessed by high-resolution computed tomography (HRCT). Radiol Med (Torino): 2005; 109 5-6 472 487 (Pubitemid 43951132)
71. Romagnoli M., Gurioli C., Casoni G., Poletti V. Surgical lung biopsy in the diagnosis of idiopathic NSIP: do we always need it in the initial approach? Am J Respir Crit Care Med: 2009; 179 11 1071, author reply 10711072
72. Sakamoto S., Homma S., Mun M., Fujii T., Kurosaki A., Yoshimura K. Acute exacerbation of idiopathic interstitial pneumonia following lung surgery in 3 of 68 consecutive patients: a retrospective study. Intern Med: 2011; 50 2 77 85
73. Bjoraker J. A., Ryu J. H., Edwin M. K., et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med: 1998; 157 1 199 203 (Pubitemid 28071283)
74. Nicholson A. G., Colby T. V., du Bois R. M., Hansell D. M., Wells A. U. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med: 2000; 162 6 2213 2217 (Pubitemid 32051689)
75. Suda T., Kono M., Nakamura Y., et al. Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). Respir Med: 2010; 104 10 1527 1534
76. Corte T. J., Copley S. J., Desai S. R., et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J: 2012; 39 3 661 668
77. Flaherty K. R., Martinez F. J. Nonspecific interstitial pneumonia. Semin Respir Crit Care Med: 2006; 27 6 652 658 (Pubitemid 46048044)
78. Jegal Y., Kim D. S., Shim T. S., et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med: 2005; 171 6 639 644 (Pubitemid 40365421)
79. Akira M., Inoue Y., Arai T., Okuma T., Kawata Y. Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia. Thorax: 2011; 66 1 61 65
80. Park I. N., Kim D. S., Shim T. S., et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest: 2007; 132 1 214 220 (Pubitemid 47068224)
81. Suda T., Kaida Y., Nakamura Y., et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med: 2009; 103 6 846 853
82. Cottin V., Donsbeck A. V., Revel D., Loire R., Cordier J. F. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med: 1998; 158 4 1286 1293 (Pubitemid 28489034)
83. Kondoh Y., Taniguchi H., Yokoi T., et al. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Eur Respir J: 2005; 25 3 528 533 (Pubitemid 40331185)
84. Nanki N., Fujita J., Yamaji Y., et al. Nonspecific interstitial pneumonia/fibrosis completely recovered by adding cyclophosphamide to corticosteroids. Intern Med: 2002; 41 10 867 870 (Pubitemid 35314791)
85. Flaherty K. R., Toews G. B., Lynch J. P. III., et al. Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. Am J Med: 2001; 110 4 278 282 (Pubitemid 32187288)
86. Raghu G., Collard H. R., Egan J. J., et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med: 2011; 183 6 788 824
87. Corte T. J., Ellis R., Renzoni E. A., et al. Use of intravenous cyclophosphamide in known or suspected, advanced non-specific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis: 2009; 26 2 132 138
88. Keir G. J., Maher T. M., Hansell D. M., et al. Severe interstitial lung disease in connective tissue disease: Rituximab as rescue therapy. Eur Respir J: 2012; Feb 9. [Epub ahead of print]
89. Khan M. L., Colby T. V., Viggiano R. W., Fonseca R. Treatment with bortezomib of a patient having hyper IgG4 disease. Clin Lymphoma Myeloma Leuk: 2010; 10 3 217 219
90. Kawabata Y., Takemura T., Hebisawa A., et al. Eosinophilia in bronchoalveolar lavage fluid and architectural destruction are features of desquamative interstitial pneumonia. Histopathology: 2008; 52 2 194 202
91. Fell C. D., Martinez F. J., Liu L. X., et al. Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med: 2010; 181 8 832 837